JP Morgan Chase’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.5M | Sell |
172,400
-387,700
| -69% | -$54.3M | ﹤0.01% | 1948 |
|
|
2025
Q4 | $68.7M | Buy |
560,100
+287,000
| +105% | +$34.9M | ﹤0.01% | 1161 |
|
|
2025
Q3 | $30.3M | Buy |
273,100
+57,400
| +27% | +$6.52M | ﹤0.01% | 1762 |
|
|
2025
Q2 | $23.9M | Buy |
215,700
+163,800
| +316% | +$17.4M | ﹤0.01% | 1823 |
|
|
2025
Q1 | $5.82M | Sell |
51,900
-35,500
| -41% | -$3.66M | ﹤0.01% | 3022 |
|
|
2024
Q4 | $8.07M | Sell |
87,400
-60,000
| -41% | -$5.4M | ﹤0.01% | 2905 |
|
|
2024
Q3 | $12.4M | Buy |
147,400
+91,000
| +161% | +$6.94M | ﹤0.01% | 2425 |
|
|
2024
Q2 | $3.87M | Sell |
56,400
-7,000
| -11% | -$467K | ﹤0.01% | 3239 |
|
|
2024
Q1 | $4.64M | Sell |
63,400
-163,300
| -72% | -$12.6M | ﹤0.01% | 3166 |
|
|
2023
Q4 | $18.4M | Sell |
226,700
-16,600
| -7% | -$1.29M | ﹤0.01% | 1928 |
|
|
2023
Q3 | $18.2M | Buy |
243,300
+90,700
| +59% | +$6.98M | ﹤0.01% | 1751 |
|
|
2023
Q2 | $11.8M | Sell |
152,600
-250,900
| -62% | -$20M | ﹤0.01% | 2157 |
|
|
2023
Q1 | $33.5M | Sell |
403,500
-275,300
| -41% | -$22.8M | ﹤0.01% | 1313 |
|
|
2022
Q4 | $58.3M | Buy |
678,800
+62,500
| +10% | +$4.95M | 0.01% | 1033 |
|
|
2022
Q3 | $38M | Buy |
616,300
+174,300
| +39% | +$11M | 0.01% | 1176 |
|
|
2022
Q2 | $27.3M | Buy |
442,000
+188,000
| +74% | +$11.6M | ﹤0.01% | 1387 |
|
|
2022
Q1 | $15.1M | Sell |
254,000
-391,900
| -61% | -$25.1M | ﹤0.01% | 2000 |
|
|
2021
Q4 | $46.9M | Sell |
645,900
-558,400
| -46% | -$38.5M | 0.01% | 1248 |
|
|
2021
Q3 | $84.1M | Buy |
1,204,300
+1,011,700
| +525% | +$71.1M | 0.01% | 946 |
|
|
2021
Q2 | $13.3M | Sell |
192,600
-7,800
| -4% | -$521K | ﹤0.01% | 2186 |
|
|
2021
Q1 | $13M | Sell |
200,400
-469,800
| -70% | -$30.3M | ﹤0.01% | 2124 |
|
|
2020
Q4 | $39M | Buy |
670,200
+22,700
| +4% | +$1.37M | 0.01% | 1192 |
|
|
2020
Q3 | $40.2M | Buy |
647,500
+112,500
| +21% | +$7.8M | 0.01% | 1088 |
|
|
2020
Q2 | $41.2M | Sell |
535,000
-92,300
| -15% | -$7.07M | 0.01% | 982 |
|
|
2020
Q1 | $46.9M | Sell |
627,300
-167,800
| -21% | -$11.6M | 0.01% | 828 |
|
|
2019
Q4 | $51.7M | Buy |
795,100
+217,100
| +38% | +$14.1M | 0.01% | 942 |
|
|
2019
Q3 | $36.6M | Buy |
578,000
+315,000
| +120% | +$20.6M | 0.01% | 1122 |
|
|
2019
Q2 | $17.6M | Sell |
263,000
-190,600
| -42% | -$12.5M | ﹤0.01% | 1657 |
|
|
2019
Q1 | $29.5M | Sell |
453,600
-27,900
| -6% | -$1.85M | 0.01% | 1266 |
|
|
2018
Q4 | $30.1M | Sell |
481,500
-30,400
| -6% | -$2.12M | 0.01% | 1186 |
|
|
2018
Q3 | $39.5M | Buy |
511,900
+52,500
| +11% | +$3.96M | 0.01% | 1157 |
|
|
2018
Q2 | $32.5M | Buy |
459,400
+147,400
| +47% | +$10.4M | 0.01% | 1237 |
|
|
2018
Q1 | $23.5M | Sell |
312,000
-582,200
| -65% | -$46.3M | 0.01% | 1395 |
|
|
2017
Q4 | $64.1M | Buy |
894,200
+242,200
| +37% | +$18.4M | 0.01% | 859 |
|
|
2017
Q3 | $52.8M | Sell |
652,000
-108,000
| -14% | -$8.26M | 0.01% | 896 |
|
|
2017
Q2 | $53.8M | Buy |
760,000
+196,600
| +35% | +$13.1M | 0.01% | 872 |
|
|
2017
Q1 | $38.3M | Sell |
563,400
-37,100
| -6% | -$2.61M | 0.01% | 1073 |
|
|
2016
Q4 | $43M | Buy |
600,500
+358,750
| +148% | +$26.7M | 0.01% | 974 |
|
|
2016
Q3 | $19.1M | Buy |
241,750
+100,685
| +71% | +$8.18M | ﹤0.01% | 1403 |
|
|
2016
Q2 | $11.8M | Buy |
141,065
+56,065
| +66% | +$4.98M | ﹤0.01% | 1740 |
|
|
2016
Q1 | $7.81M | Sell |
85,000
-1,151,500
| -93% | -$104M | ﹤0.01% | 1925 |
|
|
2015
Q4 | $125M | Buy |
1,236,500
+106,000
| +9% | +$11M | 0.03% | 495 |
|
|
2015
Q3 | $111M | Sell |
1,130,500
-68,047
| -6% | -$7.56M | 0.03% | 514 |
|
|
2015
Q2 | $140M | Buy |
1,198,547
+12,110
| +1% | +$1.32M | 0.03% | 487 |
|
|
2015
Q1 | $116M | Sell |
1,186,437
-1,549,963
| -57% | -$157M | 0.03% | 582 |
|
|
2014
Q4 | $258M | Buy |
2,736,400
+29,650
| +1% | +$3.07M | 0.06% | 351 |
|
|
2014
Q3 | $288M | Buy |
2,706,750
+1,000,150
| +59% | +$97.9M | 0.07% | 310 |
|
|
2014
Q2 | $141M | Hold |
1,706,600
| – | – | 0.04% | 473 |
|
|
2014
Q1 | $121M | Sell |
1,706,600
-7,304,000
| -81% | -$573M | 0.03% | 493 |
|
|
2013
Q4 | $677M | Sell |
9,010,600
-800
| -0% | -$55.7K | 0.19% | 113 |
|
|
2013
Q3 | $567M | Sell |
9,011,400
-126,100
| -1% | -$7.54M | 0.17% | 138 |
|
|
2013
Q2 | $468M | Buy |
+9,137,500
| New | +$476M | 0.15% | 151 |
|
Other funds holding GILD
VCM
VPM
JP Morgan Chase's GILD Position: Q1 2026 in Review
JP Morgan Chase increased its Gilead Sciences (GILD) stake by 48% in Q1 2026, buying an estimated $1.53B and bringing the position to 33,992,410 shares worth $4.63B. The position accounts for 0.3% of the portfolio, ranked #69.
JP Morgan Chase first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- JP Morgan Chase held 33,992,410 shares of Gilead Sciences worth $4.63B as of Q1 2026.
- JP Morgan Chase bought 10,956,647 Gilead Sciences shares in Q1 2026, an estimated $1.53B.
- Gilead Sciences made up 0.3% of JP Morgan Chase's portfolio in Q1 2026, its #69 holding.
- JP Morgan Chase first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.